JPRN-UMIN000007793
Completed
N/A
A prospective observational study for a validation of National Institutes of Health criteria for late-acute and chronic GVHD (KSGCT1201 / NIH-GVHD STUDY) - KSGCT1201 / NIH-GVHD STUDY
Kanto Study Group for Cell Therapy0 sites400 target enrollmentApril 20, 2012
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Allogeneic hematopoietic stem cell transplantation
- Sponsor
- Kanto Study Group for Cell Therapy
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients without written informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
A prospective observational study to evaluate appropriate extubation time of postoperative patients using chest X-ray Dynamic Digital Radiography (DDR).postoperative patients on mechanical ventilationJPRN-UMIN000053288Tohoku University200
Not Yet Recruiting
N/A
Prospective observational study for the evaluation of new biomarkers in urine for acute kidney injury after cardiac surgery.N17.9Acute renal failure, unspecifiedDRKS00005062niversity Hospital Münster100
Recruiting
N/A
Prospective observational study for the evaluation of recurrences/primary hernias and technical or postoperative complications in the context of surgical practice for the treatment/prevention of abdominal wall, inguinal, diaphragm and parastomal hernias with DynaMesh® mesh implantsEpigastric Hernias, Hiatus Hernias, Prevention and Treatment of Incisional Hernias, Inguinal Hernias, Umbilical Hernias, Treatment and Prevention of Parastomal HerniasDRKS00031191FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH120
Recruiting
N/A
Observational study;Prospective validation study Dutch version walking impairment Questionnaire (WIQ).1. Peripheral arterial disease<br />2. Intermittent claudication<br /> (NLD: Perifeer arterieel vaatlijden,etalagebenen, Claudicatio intermittens).NL-OMON24806Dr. J.A.W TeijinkAtrium medisch centrumPostbus 44466401 CX HeerlenJ.Teijink@atriummc.nl30
Completed
N/A
Prospective observational study to evaluate appropriate dosage and efficacy of cephamycin and oxacephem for invasive UTI due to ESBL-E. coliinvasive UTIJPRN-UMIN000041639CGM78